Unknown PHASE1 INTERVENTIONAL 2-arm NCT01845272

Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate (CCA)

Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate in Healthy Male Volunteers.

Sponsor: HK inno.N Corporation

Conditions Healthy

Interventions candesartan cilexetil 32mg, amlodipine 10mg

Updated 6 times since 2017 Last updated: Apr 30, 2013 Started: Apr 30, 2013 Primary completion: Jul 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01845272, this PHASE1 trial focuses on Healthy and remains ongoing. Sponsored by HK inno.N Corporation, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Aug 2020 — Jan 2021 [monthly]

Unknown Status PHASE1
Jun 2018 — Aug 2020 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HK inno.N Corporation

Data source: HK inno.N Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.